Agenus Inc. (AGEN): Price and Financial Metrics

AGEN POWR Grades

• Value is the dimension where AGEN ranks best; there it ranks ahead of 93.95% of US stocks.
• AGEN's strongest trending metric is Value; it's been moving up over the last 179 days.
• AGEN's current lowest rank is in the Momentum metric (where it is better than 4.64% of US stocks).

AGEN Stock Summary

• Agenus Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 96.36% of US listed stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at -3.69 for Agenus Inc; that's greater than it is for only 3.09% of US stocks.
• As for revenue growth, note that AGEN's revenue has grown 235.33% over the past 12 months; that beats the revenue growth of 96.48% of US companies in our set.
• Stocks that are quantitatively similar to AGEN, based on their financial statements, market capitalization, and price volatility, are EVGN, DNN, EIGR, GNCA, and SIMO.
• Visit AGEN's SEC page to see the company's official filings. To visit the company's web site, go to agenusbio.com.

AGEN Valuation Summary

• AGEN's price/earnings ratio is -6.4; this is 117.53% lower than that of the median Healthcare stock.
• Over the past 243 months, AGEN's EV/EBIT ratio has gone down 1.3.
• Over the past 243 months, AGEN's price/earnings ratio has gone up 2.5.

Below are key valuation metrics over time for AGEN.

AGEN Growth Metrics

The year over year cash and equivalents growth rate now stands at 29.35%.
• Its year over year price growth rate is now at 16.73%.
• Its 5 year net income to common stockholders growth rate is now at -69.15%.

Over the past 15 months, AGEN's revenue has gone up $204,260,000.

The table below shows AGEN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	295.665	10.145	-24.137
2021-09-30	306.667	-2.518	3.767
2021-06-30	68.545	-165.517	-225.937
2021-03-31	84.76	-147.335	-190.126
2020-12-31	88.17	-139.096	-181.123
2020-09-30	91.405	-135.286	-173.57

AGEN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• AGEN has a Quality Grade of C, ranking ahead of 55.26% of graded US stocks.
• AGEN's asset turnover comes in at 0.324 -- ranking 139th of 681 Pharmaceutical Products stocks.
• COCP, MTEM, and LGND are the stocks whose asset turnover ratios are most correlated with AGEN.

The table below shows AGEN's key quality metrics over time.